ArticleBMJ open diabetes research & care2025

SGLT2 inhibitor use and renal outcomes in low-risk population with diabetes mellitus and normal or low body mass index.

Yun Soo Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.